AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Corvus Pharmaceuticals, Inc. Director's Dealing 2020

May 6, 2020

32755_dirs_2020-05-06_82a2e4e0-f632-4208-bc85-802f4887baf5.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2020-04-30

Reporting Person: Novo Holdings A/S (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
COMMON STOCK	2927560	Direct